EA009872B1 - АНТИ-Aβ АНТИТЕЛА - Google Patents

АНТИ-Aβ АНТИТЕЛА Download PDF

Info

Publication number
EA009872B1
EA009872B1 EA200601545A EA200601545A EA009872B1 EA 009872 B1 EA009872 B1 EA 009872B1 EA 200601545 A EA200601545 A EA 200601545A EA 200601545 A EA200601545 A EA 200601545A EA 009872 B1 EA009872 B1 EA 009872B1
Authority
EA
Eurasian Patent Office
Prior art keywords
antibody
peptide
cells
antibodies
secretase
Prior art date
Application number
EA200601545A
Other languages
English (en)
Russian (ru)
Other versions
EA200601545A1 (ru
Inventor
Рональд Брэдли Дематтос
Ума Кучибхотла
Си-Чиун Ян
Дон Б. Макклур
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200601545A1 publication Critical patent/EA200601545A1/ru
Publication of EA009872B1 publication Critical patent/EA009872B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
EA200601545A 2004-02-23 2005-02-17 АНТИ-Aβ АНТИТЕЛА EA009872B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54676404P 2004-02-23 2004-02-23
PCT/US2005/005198 WO2005082939A2 (en) 2004-02-23 2005-02-17 Anti-abeta antibody

Publications (2)

Publication Number Publication Date
EA200601545A1 EA200601545A1 (ru) 2007-02-27
EA009872B1 true EA009872B1 (ru) 2008-04-28

Family

ID=34910810

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601545A EA009872B1 (ru) 2004-02-23 2005-02-17 АНТИ-Aβ АНТИТЕЛА

Country Status (20)

Country Link
US (1) US20070190046A1 (https=)
EP (1) EP1720909B1 (https=)
JP (1) JP4851348B2 (https=)
KR (2) KR20090005410A (https=)
CN (1) CN1922209B (https=)
AT (1) ATE534667T1 (https=)
AU (1) AU2005217596B2 (https=)
BR (1) BRPI0507856A (https=)
CA (1) CA2556436C (https=)
CY (1) CY1112162T1 (https=)
DK (1) DK1720909T3 (https=)
EA (1) EA009872B1 (https=)
ES (1) ES2375627T3 (https=)
IL (1) IL177611A (https=)
NO (1) NO20064239L (https=)
PL (1) PL1720909T3 (https=)
PT (1) PT1720909E (https=)
SI (1) SI1720909T1 (https=)
UA (1) UA93181C2 (https=)
WO (1) WO2005082939A2 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
PL2289909T3 (pl) 2005-11-30 2015-04-30 Abbvie Inc Sposób przeszukiwania, proces oczyszczania niedyfundujących oligomerów Abeta, selektywne przeciwciała przeciw niedyfundującym oligomerom Abeta i sposób wytwarzania tych przeciwciał
RU2432362C2 (ru) 2005-11-30 2011-10-27 Эбботт Лэборетриз Моноклональные антитела и их применения
SG10201404801YA (en) 2005-12-12 2014-09-26 Ac Immune Sa Monoclonal antibody
NZ574188A (en) 2006-07-14 2012-05-25 Ac Immune Sa Humanized antibody against amyloid beta
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
KR20120017469A (ko) 2007-01-05 2012-02-28 유니버시티 오브 취리히 질환 특이적 결합 분자 및 표적을 제공하는 방법
HRP20140049T1 (hr) 2007-01-05 2014-02-28 University Of Zürich Anti beta-amiloid antitijela i njihova upotreba
JP2010515717A (ja) 2007-01-11 2010-05-13 フィリップス−ウニベルジテート・マールブルク アルツハイマーおよび他の神経性認知症疾患の診断ならびに処置
EP2124952A2 (en) 2007-02-27 2009-12-02 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
US8048420B2 (en) * 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
US8613923B2 (en) * 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
RS53174B (sr) 2007-10-05 2014-06-30 Genentech Inc. Upotreba antiamiloidnog beta antitela u slučaju oboljenja oka
SG178809A1 (en) * 2007-10-05 2012-03-29 Genentech Inc Use of anti-amyloid beta antibody in ocular diseases
JP5773879B2 (ja) 2008-11-25 2015-09-02 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． 神経系の細胞の生存を促進するためのＤＲ６およびｐ７５のアンタゴニストの使用
AU2009328505B2 (en) 2008-12-19 2014-11-27 Panima Pharmaceuticals Ag Human anti-alpha-synuclein autoantibodies
KR20120103587A (ko) 2009-11-12 2012-09-19 제넨테크, 인크. 수상돌기 소극 밀도를 증진시키는 방법
ES2684475T3 (es) 2010-04-15 2018-10-03 Abbvie Inc. Proteínas que se unen a beta amiloide
RU2607368C2 (ru) 2010-07-30 2017-01-10 Ац Иммуне С.А. Безопасные и функциональные гуманизированные антитела
PT3042917T (pt) * 2010-08-12 2018-05-02 Lilly Co Eli Anticorpos do péptido beta amilóide anti-n3pglu e seus usos
CN103298833B (zh) 2010-08-14 2015-12-16 Abbvie公司 β淀粉样蛋白结合蛋白
HUE041391T2 (hu) 2011-06-23 2019-05-28 Biogen Int Neuroscience Gmbh Anti-alfa-szinukleinkötõ molekulák
CA2884309A1 (en) 2012-09-07 2014-03-13 Massachusetts Eye And Ear Infirmary Methods and compositions for regenerating hair cells and/or supporting cells from differentiated cochlear cells or differentiated utricular cells by modulation of notch and cmyc activity
CA2883896C (en) 2012-09-07 2023-03-07 Massachusetts Eye & Ear Infirmary Treating hearing loss
EP4331605A3 (en) 2013-09-13 2024-05-22 F. Hoffmann-La Roche AG Methods and compositions comprising purified recombinant polypeptides
MA41115A (fr) 2014-12-02 2017-10-10 Biogen Int Neuroscience Gmbh Procédé de traitement de la maladie d'alzheimer
JP6840774B2 (ja) 2016-05-16 2021-03-10 ザ ジェネラル ホスピタル コーポレイション 肺上皮エンジニアリングにおけるヒト気道幹細胞
JP2019524788A (ja) * 2016-08-11 2019-09-05 イーライ リリー アンド カンパニー アミノチアジンおよびｂａｃｅ１阻害剤としてのそれらの使用
IL272773B2 (en) 2017-08-22 2024-06-01 Biogen Ma Inc Pharmaceutical preparations containing anti-amyloid cell antibodies
TWI843040B (zh) 2021-01-11 2024-05-21 美商美國禮來大藥廠 抗N3pGlu類澱粉β抗體及其用途
WO2022251048A1 (en) 2021-05-24 2022-12-01 Eli Lilly And Company Anti-amyloid beta antibodies and uses thereof
WO2023150483A1 (en) 2022-02-03 2023-08-10 Eli Lilly And Company Regional tau imaging for diagnosing and treating alzheimer's disease

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046237A2 (en) * 2000-12-06 2002-06-13 Neuralab Limited Humanized antibodies that recognize beta amyloid peptide
WO2002088306A2 (en) * 2001-04-30 2002-11-07 Eli Lilly And Company Humanized antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA002100B1 (ru) 1996-12-23 2001-12-24 Элан Фармасьютикалз, Инк. ЦИКЛОАЛКИЛЬНЫЕ СОЕДИНЕНИЯ, ЛАКТАМЫ, ЛАКТОНЫ И РОДСТВЕННЫЕ СОЕДИНЕНИЯ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И СПОСОБЫ ИНГИБИРОВАНИЯ ВЫСВОБОЖДЕНИЯ И/ИЛИ СИНТЕЗА β-АМИЛОИДНОГО ПЕПТИДА С ПОМОЩЬЮ УКАЗАННЫХ СОЕДИНЕНИЙ
US6518011B1 (en) * 1999-01-13 2003-02-11 Bristol-Myers Squibb Company Method for screening compounds to identify beta-amyloid production modulators
BRPI0108676B8 (pt) * 2000-02-24 2021-05-25 Lilly Co Eli anticorpos humanizados que sequestram peptídeo amilóide beta e seus usos no tratamento de condições caracterizadas por formação de placas amiloides, bem como composição farmacêutica que compreende os referidos anticorpos
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046237A2 (en) * 2000-12-06 2002-06-13 Neuralab Limited Humanized antibodies that recognize beta amyloid peptide
WO2002088306A2 (en) * 2001-04-30 2002-11-07 Eli Lilly And Company Humanized antibodies

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BARNES L. M. ET AL.: "Advances in animal cell recombinant protein production: GS-NSO expression system", CYTOTECHNOLOGY, vol. 32, no. 2, February 2000 (2000-02), pages 109-123, XP002301322, ISSN: 0920-9069, the whole document *
CHAUHAN NEELIMA B. ET AL.: "Intracerebroventricular passive immunization with anti-Abeta antibody 1n Tg2576", JOURNAL OF NEUROSCIENCE RESEARCH, vol. 74, no. 1, 1 October 2003 (2003-10-01), pages 142-147, XP002339442, ISSN: 0360-4012, abstract, page 143, right-hand column, last paragraph - page 144, left-hand column, paragraph 1 *
MILLER DAVID L. ET AL.: "Humoral immune response to fibrillar beta-amyloid peptide", BIOCHEMISTRY, vol. 42, no. 40, 14 October 2003 (2003-10-14), pages 11682-11692, XP002339443, ISSN: 0006-2960, page 11683, right-hand column, paragraph 2 - paragraph 3 *
YOO E. M. ET AL.: "Myeloma expression systems", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V..AMSTERDAM, NL, vol. 261, no. 1-2, 1 March 2002 (2002-03-01), pages 1-20, XP004341264, ISSN: 0022-1759, abstract, page 3, left-hand column, line 1 - line 13 table 1, page 13, right-hand column, last paragraph *

Also Published As

Publication number Publication date
CN1922209B (zh) 2012-09-05
DK1720909T3 (da) 2012-01-30
PL1720909T3 (pl) 2012-04-30
WO2005082939A2 (en) 2005-09-09
IL177611A (en) 2013-05-30
AU2005217596A1 (en) 2005-09-09
AU2005217596B2 (en) 2012-01-19
KR100889430B1 (ko) 2009-03-23
ES2375627T3 (es) 2012-03-02
SI1720909T1 (sl) 2012-01-31
CY1112162T1 (el) 2015-12-09
CN1922209A (zh) 2007-02-28
KR20060126785A (ko) 2006-12-08
BRPI0507856A (pt) 2007-07-10
CA2556436C (en) 2014-04-01
KR20090005410A (ko) 2009-01-13
EP1720909A2 (en) 2006-11-15
PT1720909E (pt) 2011-12-23
EA200601545A1 (ru) 2007-02-27
CA2556436A1 (en) 2005-09-09
JP2008500279A (ja) 2008-01-10
WO2005082939A3 (en) 2005-10-27
NO20064239L (no) 2006-11-20
UA93181C2 (ru) 2011-01-25
EP1720909B1 (en) 2011-11-23
US20070190046A1 (en) 2007-08-16
IL177611A0 (en) 2006-12-10
JP4851348B2 (ja) 2012-01-11
ATE534667T1 (de) 2011-12-15

Similar Documents

Publication Publication Date Title
EA009872B1 (ru) АНТИ-Aβ АНТИТЕЛА
JP4540132B2 (ja) Ｉｌ−６レセプター抗体を含んでなる筋蛋白分解抑制剤
JP2023116817A (ja) 抗体製剤および方法
KR20250061718A (ko) 항-인플루엔자 b 바이러스 항체, 인플루엔자 b 바이러스의 검출용 시약 및 키트
EA012162B1 (ru) Способ рефолдинга рекомбинантных антител
EA032054B1 (ru) Моноклональное антитело или его антигенсвязывающий фрагмент, его применения, клеточная линия гибридомы для его получения, фармацевтическая композиция, содержащая моноклональное антитело или его антигенсвязывающий фрагмент, способ диагностики in vitro амилоид-ассоциированного заболевания и набор для его осуществления
DE60128452T2 (de) Monoklonale antikörper gegen den menschlichen ldl-rezeptor, deren herstellung und verwendung
Richter et al. A study of two types of ferritin from rat hepatomas
EP0131834B1 (en) Monoclonal antibody having specificity to only one type of an isozyme of human cardiac myosin heavy chain
WO2025180021A1 (zh) 一种抗人与鼠TfR的抗体或其抗原结合片段及其用途
AU603053B2 (en) Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses
DE69229230T2 (de) Antikörpertest zur erkennung von alkoholikern und zur überwachung der alkoholaufnahme
Natorio et al. Role of dipeptidyl peptidase IV (gp 108) in passive Heymann nephritis. Use of dipeptidyl peptidase IV-deficient rats
CN114901313A (zh) 急性期的视神经脊髓炎的预防或治疗剂
JP2779193B2 (ja) 抗ヒト組織因子モノクローナル抗体
US20030186335A1 (en) Monoclonal antibodies, hybridomas, cell isolation method, isolated cells and immunological diagnostic method
JPH04183397A (ja) ヒト７２ｋＤａゼラチナーゼに対するモノクローナル抗体およびその利用
JP2643040B2 (ja) モノクローナル抗体
MXPA06009560A (en) Anti-abeta antibody
TW202140555A (zh) 失智症之預防或治療劑
JPH01171495A (ja) モノクローナル抗体及びそれを用いる定量法
WO1989001947A1 (fr) Proteine derivee d&#39;un corps vivant
JPH1121300A (ja) 抗ヒトトランスフェリンモノクローナル抗体及びこれを産生するハイブリドーマ細胞株
JPH0560359B2 (https=)
JPS63253098A (ja) ヒト抗体に対するモノクロ−ナル抗体、その製法及び用途

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU